Patent · US Active

MicroRNAs and uses thereof

US9133453B2 · kind B2 · utility

1Cited by
4References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2013
Grant dateSep 15, 2015
Priority date
Expiry dateMay 8, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are polynucleotides associated with prostate and lung cancer. The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of prostate and lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.